| Date Filed | Type | Description |
| 02/23/2021 |
GN
| Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio |
| 02/18/2021 |
GN
| Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19 |
| 02/24/2020 |
GN
| Interpace Announces Extension of LabCorp Agreement |
| 03/27/2019 |
GN
| Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences — Renewed Outlook, Key Drivers of Growth |
| 12/07/2018 |
GN
| Detailed Research: Economic Perspectives on PayPal, Alphabet, Southern, Interpace Diagnostics Group, Edwards Lifesciences, and Laboratory Corporation of America — What Drives Growth in Today's Competitive Landscape |
| 07/25/2018 |
GN
| Report: Developing Opportunities within Clearwater Paper, Intercept Pharmaceuticals, Community Trust, Community Bank System, Laboratory Corporation of America, and Dicerna Pharmaceuticals — Future Expectations, Projections Moving into 2018 |
| 05/18/2018 |
GN
| New Research Coverage Highlights Internap, Dime Community Bancshares, Cohu, Laboratory Corporation of America, Energy Fuels, and Obsidian Energy — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 04/25/2018 |
BW
| LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance |
| 04/12/2018 |
GN
| Hitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution Rights |
| 03/21/2018 |
GN
| Report: Developing Opportunities within Roper Technologies, Basic Energy Services, Laboratory Corporation of America, Brown Forman, Unifi, and Forrester Research -- Future Expectations, Projections Moving into 2018 |
| 03/20/2018 |
GN
| Interpace Diagnostics Announces Expansion of LabCorp National Agreement |
| 02/06/2018 |
BW
| LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance |
| 02/05/2018 |
GN
| US Ecology, Inc. Announces Appointment of Glenn A. Eisenberg to Its Board of Directors |
| 01/18/2018 |
GN
| Recent Analysis Shows LifePoint Health, Laboratory Corporation of America, Bright Horizons Family Solutions, Alleghany, CyberOptics, and Ares Management Market Influences — Renewed Outlook, Key Drivers of Growth |
| 11/09/2017 |
GN
| OmniSeq Receives CAP Accreditation and Publishes Analytical Validation Paper |
| 10/25/2017 |
BW
| LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance |
| 08/21/2017 |
GN
| OmniSeq and LabCorp Sign Exclusive Distribution Agreement and Series B Funding Commitment |
| 07/31/2017 |
BW
| LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development |
| 07/26/2017 |
BW
| LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance |
| 05/04/2017 |
BW
| LabCorp to Webcast Its Annual Meeting of Shareholders |
| 04/25/2017 |
BW
| Laboratory Corporation of America® Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance |
| 02/16/2017 |
BW
| Laboratory Corporation of America® Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance |
| 08/15/2011 |
BW
| LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. |
| 07/21/2011 |
BW
| Laboratory Corporation of America® Holdings Announces Second Quarter 2011 Results |
| 07/01/2011 |
BW
| Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 |
| 06/01/2011 |
BW
| LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories |
| 05/18/2011 |
BW
| LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. |
| 04/21/2011 |
BW
| Laboratory Corporation of America® Holdings Announces First Quarter 2011 Results |
| 04/19/2011 |
BW
| LabCorp Commences Cash Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. |
| 04/06/2011 |
BW
| LabCorp Announces Definitive Agreement to Acquire Orchid Cellmark Inc. |
| 04/04/2011 |
BW
| Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 |
| 03/14/2011 |
BW
| LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest |
| 03/09/2011 |
BW
| LabCorp is Scheduled to Present at the Barclays Capital 2011 Global Healthcare Conference |
| 02/23/2011 |
BW
| LabCorp is Scheduled to Speak at RBC Capital Markets' 2011 Healthcare Conference |
|